Latest news articles

Added 1 year ago Drug news

Cidara Therapeutics initiates ReStore Phase III study of rezafungin to treat candidiasis..

Cidara Therapeutics, Inc. announced that the first trial site has been activated for ReSTORE, a Phase III clinical trial evaluating...

Added 4 years ago Drug news

Phase III SECURE trial on Cresemba (isavuconazonium sulfate) in invasive aspergillosis published in The Lancet- Astellas

Astellas has announced that results from the pivotal Phase III SECURE trial evaluating Cresemba (isavuconazonium sulfate) in adult patients with...

Added 7 years ago Drug news

Vestiq Pharma licenses Oravig for Oropharyngeal Candidiasis in US from BioAlliance Pharma

BioAlliance Pharma has entered into a licence agreement with Vestiq Pharmaceuticals, under which the latter gains the US commercialisation rights...

Search all news articles for Mycoses

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more


British Association of Dermatologists’ guidelines for the management of onychomycosis 2014

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of onychomycosis.

Added 5 years ago

British Association of Dermatologists’ guidelines for the management of tinea capitis 2014

The overall objective of this guideline is to provide up-todate, evidence-based recommendations for the management of tinea capitis.

Added 5 years ago

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

The overall aim of this guidance is to address the difficulties in managing and diagnosing invasive fungal infections due to hyalohyphomycetes.

Added 5 years ago

Search all guidelines for Mycoses

Journal articles

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Background: Mucormycosis is an uncommon invasive fungal disease with high mortality and few treatment options. Isavuconazole is a triazole active...

Added 3 years ago

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Background: Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed efficacy and safety of isavuconazole versus...

Added 4 years ago

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.

Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause...

Added 4 years ago

Search all journal articles for Mycoses